The Asia and Pacific Alliance to Eliminate Viral Hepatitis (APAVH) is a new global initiative established in November 2008, by the US Centers for Disease Control and Prevention (US CDC), the World Health Organization (WHO), and the Asian Liver Center at Stanford University (ALC) to create a sustainable transnational public private partnership to eliminate viral hepatitis infection and reduce the complications of chronic viral hepatitis through education, advocacy, prevention, vaccination, and access to care and treatment. Public-private partnerships allow capitalizing on partners’ scientific experience, strengthening weaknesses, and building collaborations and sustainability that can produce better outcomes than otherwise possible. By forging a collaborative network of partnering orga... (more)

The Asia and Pacific Alliance to Eliminate Viral Hepatitis (APAVH) is a new global initiative established in November 2008, by the US Centers for Disease Control and Prevention (US CDC), the World Health Organization (WHO), and the Asian Liver Center at Stanford University (ALC) to create a sustainable transnational public private partnership to eliminate viral hepatitis infection and reduce the complications of chronic viral hepatitis through education, advocacy, prevention, vaccination, and access to care and treatment. Public-private partnerships allow capitalizing on partners’ scientific experience, strengthening weaknesses, and building collaborations and sustainability that can produce better outcomes than otherwise possible. By forging a collaborative network of partnering organizations and by developing a comprehensive shared resource database, countries and their health agencies will be able to share replicable programs dealing with vaccination strategies, education campaigns, and advocacy. APAVH will assist in review and development of regional and country specific goals and promotion of the implementation of WHO regional recommendations.

Partners of this new global initiative will consist of an experienced multi-disciplinary alliance of public health practitioners, foundations, policymakers, government agencies, academicians, scientists, patient and advocacy groups, legal professionals, business groups, and the pharmaceutical industry, among others. (less)